Tandem Diabetes Care (TNDM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 185,622 | 195,917 | 169,383 | 220,501 | 204,547 |
| Cost of Goods | 95,869 | 94,182 | 86,476 | 104,979 | 100,122 |
| Gross Profit | 89,753 | 101,735 | 82,907 | 115,522 | 104,425 |
| Operating Expenses | 122,167 | 140,725 | 211,200 | 134,279 | 152,040 |
| Operating Income | -31,545 | -38,808 | -127,817 | -17,778 | -47,493 |
| Interest Expense | 4,840 | 1,605 | 1,634 | 1,579 | 1,576 |
| Other Income | 5,656 | 5,784 | 5,865 | 3,243 | 1,720 |
| Pre-tax Income | -30,729 | -34,629 | -123,586 | -16,114 | -47,349 |
| Income Tax | 2,232 | 1,146 | 287 | -261 | 1,621 |
| Net Income Continuous | -32,961 | -35,775 | -123,873 | -15,853 | -48,970 |
| Net Income | $-32,961 | $-35,775 | $-123,873 | $-15,853 | $-48,970 |
| EPS Basic Total Ops | -0.51 | -0.55 | -1.92 | -0.25 | -0.76 |
| EPS Basic Continuous Ops | -0.51 | -0.55 | -1.92 | -0.25 | -0.76 |
| EPS Diluted Total Ops | -0.51 | -0.55 | -1.92 | -0.24 | -0.76 |
| EPS Diluted Continuous Ops | -0.51 | -0.55 | -1.92 | -0.25 | -0.76 |
| EBITDA(a) | $-25,398 | $-32,594 | $-123,606 | $-12,830 | $-41,904 |